145 related articles for article (PubMed ID: 4869693)
1. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
[No Abstract] [Full Text] [Related]
2. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.
Luzzatto L
Lancet; 2010 Aug; 376(9742):739-41. PubMed ID: 20599264
[No Abstract] [Full Text] [Related]
3. Haemolytic effects of DDS in leprosy patients.
Khaire DS; Magar NG
Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
[No Abstract] [Full Text] [Related]
4. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Pamba A; Richardson ND; Carter N; Duparc S; Premji Z; Tiono AB; Luzzatto L
Blood; 2012 Nov; 120(20):4123-33. PubMed ID: 22993389
[TBL] [Abstract][Full Text] [Related]
5. Is dapsone safe?
Pettit JH
Int J Dermatol; 1981 Mar; 20(2):106-7. PubMed ID: 7216589
[No Abstract] [Full Text] [Related]
6. Antimalarial studies on 4,4-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals.
Thompson PE
Int J Lepr Other Mycobact Dis; 1967; 35(4):605-15. PubMed ID: 5626306
[No Abstract] [Full Text] [Related]
7. The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria.
Willerson D; Rieckmann KH; Kass L; Carson PE; Frischer H; Bowman JE
Am J Trop Med Hyg; 1972 Mar; 21(2):138-43. PubMed ID: 4551432
[No Abstract] [Full Text] [Related]
8. [A case of acute drug-induced hemolytic anemia associated with glucoso-6-phosphate dehydrogenase deficiency].
Dul'tsina SM; Matveev MP; Shatunova LV
Vopr Okhr Materin Det; 1967 Feb; 12(2):81-4. PubMed ID: 5611382
[No Abstract] [Full Text] [Related]
9. Supplemental sulfone (dapsone) therapy. Use in treatment of chloroquine-resistant falciparum malaria.
Sheehy TW; Reba RC; Neff TA; Gaintner JR; Tigertt WD
Arch Intern Med; 1967 Jun; 119(6):561-6. PubMed ID: 5338485
[No Abstract] [Full Text] [Related]
10. Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy.
Todd P; Samaratunga IR; Pembroke A
Clin Exp Dermatol; 1994 May; 19(3):217-8. PubMed ID: 8033379
[TBL] [Abstract][Full Text] [Related]
11. Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
Onadeko BO; Bademosi O
Ir J Med Sci; 1974 Jul; 143(4):208-13. PubMed ID: 4852166
[No Abstract] [Full Text] [Related]
12. Acute haemolytic anaemia in glucose-6-phosphatase dehydrogenase deficient children.
Bakshi S; Kumar V; Das KC
Indian Pediatr; 1972 Nov; 9(11):691-6. PubMed ID: 4658686
[No Abstract] [Full Text] [Related]
13. [Role of congenital erythrocytoenzymopenia--glucose-6-phosphate dehydrogenase deficiency--in development of acute, drug-induced hemolytic anemia].
Alekseev GA
Vestn Akad Med Nauk SSSR; 1968; 23(4):81-8. PubMed ID: 5739081
[No Abstract] [Full Text] [Related]
14. Dapsone-Associated Hemolytic Anemia in Renal Transplant Recipients With Normal Glucose-6-Phosphate-Dehydrogenase Levels.
Khatri A; Lal M R S; Bhaskaran MC
Am J Ther; 2022 May-Jun 01; 29(3):e369-e372. PubMed ID: 32947344
[No Abstract] [Full Text] [Related]
15. [Erythrocyte glucosephosphate dehydrogenase deficiency as a factor in a drug-induced hemolytic crisis in a patient of Asiatic origin].
Jabłońska-Skwiecińska E; Przybylska-Dargiewicz Z; Sawicka B; Pertkiewicz M
Pol Tyg Lek; 1983 Sep; 38(38):1181-4. PubMed ID: 6672800
[No Abstract] [Full Text] [Related]
16. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
[TBL] [Abstract][Full Text] [Related]
17. [Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase].
Collombel C; Kissen C; Dorche C; Baltassat P; Cotte J
Eur J Toxicol; 1970; 3(1):42-8. PubMed ID: 5520461
[No Abstract] [Full Text] [Related]
18. [Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia in a Danish boy].
Heilmann C; Hanel HK; Jørgensen E
Ugeskr Laeger; 1980 Aug; 142(35):2284-5. PubMed ID: 7423651
[No Abstract] [Full Text] [Related]
19. Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man.
Clyde DF; Rebert CC; McCarthy VC; Dawkins AT; Cucinell SA
Mil Med; 1970 Jul; 135(7):527-36. PubMed ID: 4991753
[No Abstract] [Full Text] [Related]
20. Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Rochford R; Ohrt C; Baresel PC; Campo B; Sampath A; Magill AJ; Tekwani BL; Walker LA
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17486-91. PubMed ID: 24101478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
